about
Impact of aging on frontostriatal reward processing.Disease activity following pregnancy-related discontinuation of natalizumab in MS.CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSDLong-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Iris Kleerekooper
@en
Iris Kleerekooper
@nl
type
label
Iris Kleerekooper
@en
Iris Kleerekooper
@nl
prefLabel
Iris Kleerekooper
@en
Iris Kleerekooper
@nl
P31
P496
0000-0001-6456-9034